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        Double-positive (DP) thymocytes express TCR     
on their surface and actively rearrange the TCR      
locus. After TCR     rearrangement and expression 
of surface heterodimeric TCR     /     , DP thymo-
cytes have three fates, depending on the avidity 
of the TCR::self peptide-MHC interaction. 
Cells that undergo a weak and transient inter-
action with self peptide-MHC will be positively 
selected, survive, and mature into CD4 or CD8 
single-positive (SP) T cells, whereas a strong and 
prolonged interaction will result in elimination 
by negative selection. A total lack of signal re-
sults in death by neglect (for review see refer-
ences [  1, 2  ]). During positive selection, there are 
complex changes in gene expression, including 
the coreceptor genes CD4 and CD8 (  3  ), CD69 
(  4  ), CD5 (  5, 6  ), and TCR      (  1  ). Signaled DP 
thymocytes also induce expression of BCL2 
and IL7R     , which are both required for sur-
vival of mature T lymphocytes (  7, 8  ). Several 
transcription factors found to be either direct 
or immediate-early targets of TCR signaling, 
such as SAP1 (ELK4) (  9  ), EGR1 (  10  ), Id3 (  11  ), 
and NFAT4 (  12  ) were shown to control posi-
tive selection of both CD4 and CD8 lineages. 
Runx1 was also recently shown to alter selec-
tion of both lineages (  13  ). Other transcription 
factors act later and have a diff  erential role in 
positive selection of CD4 or CD8 lineages and 
commitment, such as Thpok/cKrox for the CD4 
lineage (  14, 15  ), Runx3 (  16  ), and Tox for the 
CD8 lineage (  17, 18  ). Transcriptional control 
of the DP stage of T cell development still re-
mains poorly defi  ned. 
  BCL11B is a C  2  H  2   zinc finger protein 
found to act both as a transcriptional repressor 
and activator (  19  –  22  ). Germline removal of 
BCL11B alters early stages of T cell develop-
ment, with a block at the DN3 stage, and causes 
enhanced susceptibility to apoptosis (  23  ). The 
role of BCL11B at the DP stage of T cell de-
velopment and beyond this stage is unknown. 
We provide evidence herein that BCL11B 
plays an essential and unique role in controlling 
early events of positive selection and survival of 
DP thymocytes. 
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  Transcriptional control of gene expression in double-positive (DP) thymocytes remains 
poorly understood. We show that the transcription factor BCL11B plays a critical role 
in DP thymocytes by controlling positive selection of both CD4 and CD8 lineages. 
BCL11B-defi  cient DP thymocytes rearrange T cell receptor (TCR)     ; however, they display 
impaired proximal TCR signaling and attenuated extracellular signal-regulated kinase 
phosphorylation and calcium fl  ux, which are all required for initiation of positive selection. 
Further, provision of transgenic TCRs did not improve positive selection of BCL11B-
defi  cient DP thymocytes. BCL11B-defi  cient DP thymocytes have altered expression of 
genes with a role in positive selection, TCR signaling, and other signaling pathways 
intersecting the TCR, which may account for the defect. BCL11B-defi  cient DP thymocytes 
also presented increased susceptibility to spontaneous apoptosis associated with high 
levels of cleaved caspase-3 and an altered balance of proapoptotic/prosurvival factors. 
This latter susceptibility was manifested even in the absence of TCR signaling and was 
only partially rescued by provision of the BCL2 transgene, indicating that control of DP 
thymocyte survival by BCL11B is nonredundant and, at least in part, independent of BCL2 
prosurvival factors. 3004 BCL11B REGULATES THYMOCYTE SELECTION AND SURVIVAL | Albu et al.
(  Fig. 1   and Fig. S2, available at http://www.jem.org/cgi/
content/full/jem.20070863/DC1), and their total cellularity 
was increased (  Table I   and   Table II  ), whereas the increase in 
the cervical lymph nodes and total cellularity was more modest 
(  Table I  ).      The percentages and absolute numbers of CD4  +   and 
CD8  +   T lymphocytes were reduced in lymph nodes and spleen 
(  Fig. 3, A and B  ;   Table I   and   Table II  ).   TCR      levels were re-
duced in the small number of BCL11B-defi  cient peripheral 
T lymphocytes (  Fig. 3 C  ), suggesting that they are immature. 
In addition, there was a major reduction in the percentage of naive 
CD62L  high  CD44  low   CD4  +   and CD8  +   T lymphocyte popula-
tions, whereas the CD44  high   populations, comprising activated 
and memory-like T cells, were increased (  Fig. 3 D  ), results which 
suggest a homeostatic deregulation in CD4  +   and CD8  +   T lym-
phocyte populations, which is often observed in lymphopenic 
mice (  26  ). The lymph nodes and spleens of BCL11B  F/F    CD4cre 
mice presented a marked increase in percentage and absolute 
numbers of B220  +   lymphocytes (  Table I   and   Table II  ). In addi-
tion to the increased numbers of B220  +   lymphocytes, the spleens 
of BCL11B  F/F  CD4cre mice presented increased numbers of 
macrophages, dendritic cells, NK, megakaryocytes and TCR          
populations (  Table II  ), suggesting alterations in homeostasis. 
This was not the case in a TCR         −  /  −    background (Table S1), 
demonstrating that the increase in the numbers of these popu-
lations is dependent on the presence of the few BCL11B-
defi  cient T cells present in the periphery. 
  BCL11B  –  defi  cient DP thymocytes fail to undergo 
positive selection 
  The defects in the BCL11B  F/F  CD4cre T lymphocytes are 
likely initiated by the perturbations at the DP stage at T cell 
development when BCL11B is removed. To obtain further 
    RESULTS   
  Thymic and peripheral cellularity is altered 
in BCL11B  F/F  CD4cre mice, and CD4 and CD8 SP 
thymocytes and peripheral T lymphocytes are abnormal 
  To study the role of BCL11B beyond the DN3 stage of T cell 
development, we used the   “  fl  oxed  ”   BCL11B mice (BCL11B  F/F  ) 
in which the exon 3, covering most of the BCL11B open read-
ing frame (  24  ), was fl  anked by LoxP sites (unpublished data). 
Removal of BCL11B was achieved by crossing the BCL11B  F/F   
mice with the CD4cre transgenic mice, expressing the Cre 
recombinase after       selection (  25  ). Cre-mediated removal of 
BCL11B was confi  rmed by quantitative (q) RT-PCR, immuno-
blot, and fl  ow cytometry analysis. BCL11B was removed in 
DP thymocytes, as well as in the small numbers of CD4 and 
CD8 SP thymocytes, but was still present in DN thymocytes 
(Fig. S1, available at http://www.jem.org/cgi/content/full/
jem.20070863/DC1). The antibodies used for detection of 
BCL11B correspond to an epitope in exon 2, aa 26  –  44 (  21, 22  ), 
outside of the removed exon. 
  Thymi of 5  –  6 wk old BCL11B  F/F  CD4cre mice were re-
duced in size (  Fig. 1  ), and thymic cellularity was reduced by 
35%; however, DP thymocytes were present, indicating that 
they passed      -selection (  Fig. 2, A and C  ).      There was a major 
reduction in the percentage and absolute numbers of CD4 
and CD8 SP thymocyte populations (  Fig. 2, A and C  ), sug-
gesting that their diff  erentiation from DP to SP thymocytes 
was compromised. In addition, the small numbers of BCL11B-
defi  cient CD4 and CD8 SP thymocytes have reduced levels 
of TCR      (  Fig. 2 B  ), indicating that they are immature. 
  The mesenteric lymph nodes and the spleens of BCL11B  F/F  -
CD4cre mice, as well as of the BCL11B  F/F  CD4cre/TCR 
transgenic mice (see bellow), were considerably enlarged 
  Figure 1.     Thymus size is reduced, whereas mesenteric lymph nodes and spleen are enlarged, in BCL11B  F/F  CD4cre mice. Gross photographs of 
mutant and control thymi, lymph nodes, and spleens, indicating reduction in the thymus size and increase in the mesenteric lymph nodes and spleen of 
BCL11B  F/F  CD4cre mice. Bars, 1 cm. (bottom right) Ratios of spleen weight (g) to total body weight (g) of BCL11B  F/F   (WT) and BCL11B  F/F  CD4cre (KO) mice. 
P = 1.28771E-05;   n   = 6; 10 wk old.     JEM VOL. 204, November 26, 2007 
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TCR     , and CD5 showed a profound decrease in the popula  tions 
expressing high levels of CD69, CD5, and TCR      (  Fig. 4 C  ), 
further demonstrating that positive selection was altered. 
  TCR     rearrangements occur normally in BCL11B-defi  cient 
DP thymocytes 
  Germline BCL11B-defi  cient mice have a block in      -selection 
caused by unsuccessful TCR      rearrangements (  23  ). Therefore, 
the reduction in the number of postselected DP thymocytes in 
BCL11B  F/F  CD4cre mice may be caused by the observation 
that these DP thymocytes do not appropriately rearrange TCR    . 
Analysis of TCR      rearrangements demonstrated that both 
early and late rearrangements proceeded similarly in BCL11B-
defi  cient and control DP thymocytes (  Fig. 4 D  ), indicating that 
the defect in positive selection is unlikely to be caused by im-
paired TCR      rearrangements. Thus, BCL11B does not control 
rearrangements at the TCR      locus, although it was previously 
suggested to be implicated in the control of rearrangements 
at the TCR      locus (  23  ). 
  Provision of transgenic TCRs favoring positive selection 
of CD4 or CD8 lineages failed to restore positive selection 
of BCL11B-defi  cient DP thymocytes 
  To further facilitate the examination of positive selection, 
we analyzed BCL11B  F/F  CD4cre thymocytes expressing trans-
genic TCRs that recognize specifi  c antigens presented in the 
context of MHC class I or II. Positive selection of CD4 lin-
eage was investigated with the OT-2 TCR transgenic mice 
that express a TCR composed of V     2/V     5 chains, recogniz-
ing the OVA peptide 323  –  339 in the context of MHC class 
II I-A  b   (  27  ). The analysis indicated a severe decrease in the 
percentage of CD4 SP thymocytes (  Fig. 5 A, a  ), as well as 
peripheral CD4  +   T lymphocytes (  Fig. 5 A, f  ), both in per-
centage and absolute numbers (  Fig. 5 B  ).   The same reduction 
was observed when gating on the TCR     2     5  high   popula-
tion (  Fig. 5 A, b  ). Moreover, both TCR     5  high  CD69  high   DP 
and TCR     5  high  HSA  low     thymocyte populations remained low 
(  Fig. 5 A, c and d  ), demonstrating that positive selection of 
CD4 lineage was impaired. In support of this conclusion, the 
number of TCR     2     5  high   DP thymocytes up-regulating CD5 
insight into the mechanism underlying the altered thymic 
development, we fi  rst investigated whether the reduction in 
the numbers of SP thymocytes was caused by a defect in posi-
tive selection. During positive selection, CD69 expression is 
induced (  4  ) and CD5 (  5  ) and TCR      (  1  ) are up-regulated. Our 
results show that BCL11B  F/F  CD4cre mice have a marked 
  reduction in the CD69  +  TCR       high   DP thymocyte population 
(  Fig. 4 A  ), indicating that they are unable to pass positive 
selection.   We also evaluated the percentage of HSA  low  TCR       high   
thymocyte population, which contains DP thymocytes that 
passed positive selection, as well as mature SP thymocytes, and 
found that it was lower in the BCL11B  F/F  CD4cre mice (  Fig. 
4 B  ). In addition, a detailed analysis of the surface levels of CD69, 
  Figure 2.     Removal of BCL11B in DP thymocytes results in a severe 
decrease in the number of CD4 and CD8 SP thymocytes. (A) Thymo-
cytes from BCL11B  F/F  CD4cre (KO) and BCL11B  F/F   mice (WT) were stained for 
CD4 and CD8 and analyzed by FACS. (B) Thymocytes were stained for CD4, 
CD8, and TCR     . Histograms show TCR      on gated CD4 or CD8 SP thymo-
cytes. Representative data from multiple experiments are shown. (C) Thy-
mic cellularity of BCL11B  F/F  CD4cre and control mice. Thymocytes were stained 
for CD4 and CD8 coreceptors and analyzed by FACS. Total cellularity was 
determined by counting the live cells. Absolute numbers of cells were 
calculated based on the percentage of each population and represented 
as values   ±   the SD. Cell counts should be multiplied by 10  6  . A two-tailed 
Student ’ s   t   test was applied to determine the statistical signifi  cance. Mice 
in these experiments were between 5 and 6 wk of age.     
    Table I.        Lymph node cellularity of BCL11B  F/F CD4cre  mice 
Tissue Mouse Total CD4  + CD8  + B220  + Macrophages Others
Mesenteric lymph 
  nodes
BCL11B  F/F   
  (  n   = 6)
34.8   ±   10.8 14.4   ±   4.1 7.2   ±   2.2 11.4   ±   5.9 0.4   ±   0.3 1.4   ±   0.9
BCL11B  F/F  CD4cre 
  (  n   = 6)
70.5   ±   36.4 5.1   ±   3. 3.6   ±   2.1 55.8   ±   33.7 2.0   ±   1 1.9   ±   1.2 
P value 0.00210 1.28E-08 1.97E-05 0.00016 0.00201 0.02717
Cervical lymph 
nodes
BCL11B  F/F   
  (  n   = 6)
26.1   ±   12.8 9.4   ±   4.5 5.7   ±   2.7 9.2   ±   5.3 0.4   ±   0.1 1.4   ±   2
BCL11B  F/F  CD4cre 
  (  n   = 6)
29.4   ±   17.8 1.6   ±   12    ±   1.5 23.1   ±   11.5 0.7   ±   0.2 1.9   ±   1
P value 0.30013 2.017E-07 3.85E-05 0.00155 0.00358 0.54395
Total cellularity was determined by counting the live cells. Absolute numbers were calculated based on the percentage of each population. All mice in these experiments were 
between 8 and 12 weeks of age. Absolute numbers should be multiplied by 10  6  . Two-tailed Student  ’  s   t   test was applied to determine the statistical signifi  cance.3006 BCL11B REGULATES THYMOCYTE SELECTION AND SURVIVAL | Albu et al.
these results demonstrate that, in the absence of BCL11B, 
positive selection of the CD8 lineage was impaired, and there-
fore BCL11B is essential for positive selection of both CD4 
and CD8 lineages. In addition, these results suggest that the 
defect in positive selection is not caused by the TCR itself. 
A detailed analysis of the cellularity in TCR transgenic and non-
transgenic BCL11B  F/F  CD4cre mice indicated a more severe 
decrease in the number of CD4 than in the number of CD8 
SP thymocytes in the absence of BCL11B (  Fig. 5, B and D, 
and Fig. 2 C  ), suggesting that selection of the CD4 lineage was 
more severely altered compared with the CD8 lineage. 
  Finally, provision of transgenic H-Y or OT-2 TCRs did 
not restore the absolute numbers of DP thymocytes (  Figs. 5, 
B and D  ), suggesting that survival of BCL11B-defi  cient DP 
thymocytes (see below) remains perturbed even in conditions 
that favor positive selection to CD4 or CD8 lineages. 
  BCL11B-defi  cient DP thymocytes have altered ERK 
phosphorylation, calcium fl  ux, and proximal events 
of TCR signaling 
  Signaling events downstream of the TCR play a critical role in 
positive selection. To further determine the cause of the defect 
in positive selection of BCL11B-defi  cient DP thymocytes, we 
examined their responses to TCR stimulation. Specifi  cally, we 
assessed the Ras  –  MEK  –  ERK pathway and calcium mobiliza-
tion, as these TCR responses play an essential role in positive 
selection (  29  –  31  ). Our results demonstrated that ERK phos-
phorylation was altered both in total DP (  Fig. 6 A  ), as well as 
in the presignaled CD69    −    DP thymocytes (  Fig. 6 B  ).   
  Similarly, calcium mobilization in response to TCR activa-
tion was attenuated in presignaled CD69    −    DP thymocytes (  Fig. 
6 C  ), and this was not caused by reduced levels of inositol 1,4,5-
triphosphate receptor (Fig. S3, available at http://www.jem
.org/cgi/content/full/jem.20070863/DC1). In DP thymocytes, 
calcium mobilization in response to TCR signaling results in 
nuclear translocation of the transcription factor NFAT4 (  12  ). 
Indeed, our results showed reduced nuclear translocation of 
NFAT4 in the BCL11B-defi  cient DP thymocytes (  Fig. 6 D  ), 
supporting the observation that calcium fl  ux was altered. 
  To further defi  ne the defect in the TCR signaling in BCL11B-
defi  cient DP thymocytes, we investigated proximal events of 
TCR signaling, including phosphorylation of ZAP70 kinase 
and of the adaptor molecule SLP76. Our results demonstrated 
levels was severely reduced (  Fig. 5 A, e  ). Collectively, these 
results demonstrate that antigen-specifi  c posi  tive selection of 
CD4 lineage was majorly altered in BCL11B  F/F    CD4cre mice. 
  To evaluate positive selection of CD8 lineage, we used the 
H-Y TCR transgenic mice, which express a TCR that recog-
nizes an antigen derived from the male-specifi  c Smcy protein 
in the context of H-2D  b   MHC class I and support positive 
selection of the CD8 lineage in female mice (  28  ). H-YTCR/
BCL11B  F/F  CD4cre females had reduced percentages and ab-
solute numbers of CD8 SP thymocytes (  Fig. 5 C, a, and D  ). 
Similar results were obtained when gating on the T3.70  high   
(H-YTCR  high  ) population (  Fig. 5, C [b] and D  ). The HY-
TCR  high  /HSA  low   and H-YTCR   high  CD69  +   populations con-
tinued to be low, and the surface level of CD5 was signifi  cantly 
decreased (  Fig. 5 C, c  –  e  ). Supporting the observation that 
positive selection was impaired, the peripheral CD8  +   T lym-
phocyte population was diminished (  Fig. 5 C, f  ). Collectively, 
    Table II.        Spleen cellularity of BCL11B  F/F CD4cre  mice 
Spleen
Mouse Total CD4  + CD8  + B220  + Macrophages Dendritic 
  cells
NK cells TCR         TCR            
  (CD4    −   /CD8    −   )
BCL11B  F/F   
  (  n   = 8)
39.6   ±   14.8 10.1   ±   3.8 5.5   ±   1 16.7   ±   7.2 1.2   ±   0.5 1.4   ±   0.5 1.6   ±   0.8 0.54   ±   0.4 0.45   ±   0.37
BCL11B  F/F  CD4cre 
  (  n   = 8)
76   ±   12.5 5.6   ±   2.1 2.1   ±   0.8 37.4   ±   10.7 5.1   ±   1.1 6.4   ±   1.5 5.8   ±   2.8 1.55   ±   0.5 2.78   ±   0.8
P value 0.001 0.011 4.24E-06 0.0004 3.73E-07 3.56E-06 0.001 0.012 0.00102
Total cellularity was determined by counting the live cells. Absolute numbers were calculated based on the percentage of each population. All mice in these experiments were 
between 8 and 12 weeks of age. Absolute numbers should be multiplied by 10  6  . Two-tailed Student  ’  s   t   test was applied to determine the statistical signifi  cance.
  Figure 3.     Peripheral T lymphocytes of BCL11B  F/F  CD4cre mice are 
reduced in number and present an activated/memory-like phenotype. 
Lymphocytes from lymph nodes (A) and spleen (B) of BCL11B  F/F CD4cre  (KO) 
and BCL11B  F/F   mice (WT) were stained for CD4 and CD8 and analyzed by 
FACS. (C) Lymphocytes were stained for CD4, CD8, and TCR    .  Histograms 
show TCR      on gated CD4  +   or  CD8 +   T lymphocytes. (D) Surface expression of 
CD44 and CD62L on gated CD4  +   and  CD8 +   T lymphocytes. Representative 
data from multiple experiments are shown.     JEM VOL. 204, November 26, 2007 
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as opposed to dying through negative selection, because of 
their overall reduced capacity to signal through TCR (see 
above), and also because of the observation that removal of 
BCL11B in DN3 thymocytes and in cell lines was demon-
strated to predispose them to apoptosis (  23, 32  ). To elimi-
nate the possibility that the reduction in DP thymocytes is 
caused by negative selection, we conducted the following 
experiments. (a) We crossed the BCL11B  F/F  CD4cre mice with 
TCR         −  /  −    mice in which DP thymocytes fail to undergo 
positive or negative selection and die by neglect because of 
the lack of TCR signaling. The results show that total and 
DP thymocyte absolute numbers still remained reduced in 
BCL11B  F/F  CD4cre/TCR         −  /  −    compared with TCR         −  /  −    mice 
(  Fig. 7 A  ), demonstrating that BCL11B-defi  cient DP thymo-
cytes die more even in the absence of TCR signaling.   (b) Be-
cause of the observation that the numbers of DP thymocytes were 
that both ZAP70 and SLP76 phosphorylation was altered in the 
absence of BCL11B (  Fig. 6 E  ), suggesting that early events 
upstream of calcium fl  ux and ERK phosphorylation are per-
turbed in BCL11B-defi  cient DP thymocytes. Together, these 
results suggest that BCL11B controls proximal events of TCR 
signaling and/or a pathway that regulates TCR signaling. 
  BCL11B-defi  cient DP thymocytes undergo increased 
apoptosis even in the absence of TCR signaling 
  Although the defect in positive selection can explain the re-
duced numbers of CD4 and CD8 SP thymocytes, it does not 
explain the reduction in the absolute number of DP thymo-
cytes in BCL11B  F/F  CD4cre mice (  Fig. 2 C  ). This reduction 
suggests that BCL11B-defi   cient DP thymocytes die more 
compared with wild type. Our hypothesis was that BCL11B-
defi  cient DP thymocytes have an intrinsic defect in survival, 
  Figure 4.     Positive selection of BCL11B  F/F  CD4cre DP thymocytes is diminished without alteration in TCR     locus rearrangements. (A) Thymo-
cytes were stained for CD4, CD8, TCR     , and CD69 and analyzed by FACS. CD69 and TCR      expression on gated DP thymocytes. Numbers indicate percentage 
of cells in each quadrant. (B) Thymocytes were stained for HSA and TCR      and analyzed by FACS. Numbers indicate the percentage of cells in each quadrant. 
(C) Thymocytes were stained for CD4, CD8, TCR     , CD69, and CD5. Histograms show TCR     , CD69, and CD5 levels on gated DP thymocytes. (D) Genomic 
DNA was extracted from DP thymocytes and amplifi  ed by PCR using primers specifi  c for the indicated V      and J      gene segments. Amplifi  cation of the     C 
region was used for normalization. Dividing lines indicate grouping of images from different parts of the same gel or different gels. This is one represen-
tative experiment out of four.     3008 BCL11B REGULATES THYMOCYTE SELECTION AND SURVIVAL | Albu et al.
  Figure 5.     Altered positive selection of CD8 and CD4 lineages in BCL11B  F/F  CD4cre mice expressing transgenic TCRs. (A) Positive selection analysis 
in OT2 mice. Thymocytes were stained for CD4, CD8, TCRV    2,  TCRV    5, and HSA (c), CD69 (d), or CD5 (e). (a) Surface expression of CD4 and CD8 on thymo-
cytes analyzed by FACS. Boxes indicate DP, CD4  + CD8 low  , and CD4 SP populations, and numbers represent the percentage of cells in the boxes. (b) Surface 
expression of CD4 and CD8 on gated V    2/V   5TCR high   thymocytes. Boxes indicate DP, CD4  + CD8 low  , and CD4 SP populations. The dotted line rectangle con-
tains all CD4  +   V   2/V   5TCR high   thymocytes. (c) Surface expression of HSA and V     5TCR on gated CD4  +   V   2/V   5TCR high   thymocytes.  V   5TCR high /HSA low  
population is indicated by a rectangle. (d) Surface expression of CD69 and V     5TCR on DP thymocytes. (e) Histogram showing surface expression of CD5 
on V    2/V   5TCR high   DP gated populations. (f) Surface expression of CD4 and CD8 on lymphocytes. Representative data from multiple experiments are shown. 
(B) Thymic cellularity of OT-2 TCR/BCL11B  F/F  CD4cre mice. Thymocytes were stained for CD4, CD8, TCRV     2, and TCRV     5 and analyzed by fl  ow cytometry. 
Total cellularity was determined by counting the live cells. Absolute numbers of cells were calculated based on the percentage of each population and 
represented as values   ±   the SD. Cell counts should be multiplied by 10  6 .  Two-tailed  Student ’ s   t   test was applied to determine the statistical signifi  cance. 
(C) Positive selection analysis in H-Y TCR females. Thymocytes were stained for CD4, CD8, T3.70 TCR, and HSA (c), CD69 (d) or CD5 (e). (a) Surface expression 
of CD4 and CD8 on thymocytes. Boxes indicate DP, CD8  + CD4 low  , and CD8 SP populations, and the numbers represent the percentage of cells in the boxes. 
(b) Surface expression of CD4 and CD8 on gated T3.70 TCR  high   thymocytes. Boxes indicate DP, CD8  + CD4 low  , and CD8 SP populations. The dotted line rectangle JEM VOL. 204, November 26, 2007 
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positive selection is cell intrinsic. Similarly, the numbers of 
reconstituted OT2/BCL11B  F/F  CD4cre DP thymocytes re-
mained reduced compared with OT2/BCL11B  F/F   DP thymo-
cytes (Table S2), despite the observation that the reconstitutions 
were initiated with the same numbers of bone marrow cells. 
One possible explanation for the enhanced cell death that we 
observed in BCL11B  F/F  CD4cre TCR transgenic mice com-
pared with polyclonal TCR background may be related to 
the observation that the expression of TCR transgenes is ini-
tiated before cells become DP (  33  ). Although in wild-type 
mice this may favor an earlier selection compared with a poly-
clonal background, it is possible that in BCL11B  F/F  CD4cre 
mice, the cells that express TCR, but fail to be selected, die. 
This is plausible because removal of the fl  oxed allele in CD4-
Cre model is initiated past DN3 stage and continues on during 
the DP stage (  25  ). 
severely reduced in conditions of provision of transgenic 
TCRs in BCL11B  F/F  CD4cre mice (  Fig. 5, B and D  ), to 
further eliminate the possibility that TCR signaling itself 
induces active cell death in TCR transgenic BCL11B  F/F  CD4cre 
mice, we conducted reconstitution experiments with OT2/
BCL11B  F/F  CD4cre bone marrow cells in nonselective (I-A  d  ) 
versus selective (I-A  b  ) recipients. Our results demonstrate that 
even in a nonselective (I-A  d  ) background the absolute num-
bers of OT2/BCL11B  F/F  CD4cre DP thymocytes were still 
reduced compared with OT2/BCL11B  F/F   DP thymocytes 
(Table S2, available at http://www.jem.org/cgi/content/full/
jem.20070863/DC1), again demonstrating that even in the 
absence of TCR signaling they die more. On a selective back-
ground (I-A  b  ), formation of CD4 SP thymocytes in mice 
reconstituted with OT2/BCL11B  F/F  CD4cre bone marrow re-
mained impaired (Table S2), demonstrating that the defect in 
contains all CD8  +   T3.70  TCR high   thymocytes. (c) Surface expression of HSA and T3.70 TCR on all CD8  +   gated thymocytes. The T3.70 TCR  high /HSA low   population 
is indicated by a rectangle. (d) Surface expression of CD69 and T3.70 TCR on DP gated populations. (e) Histogram showing surface expression of CD5 on T3.70 
TCR  high   DP gated populations. (f) Surface expression of CD4 and CD8 on lymphocytes. These are representative experiments out of four. (D) Thymic cellularity 
of H-Y TCR/BCL11B  F/F  CD4cre female mice. Thymocytes were stained for HY-TCR, CD4, and CD8 coreceptors and analyzed by fl  ow cytometry. Thymic cellular-
ity was calculated as described in B. Cell counts should be multiplied by 10  6  . Two-tailed Student  ’  s   t   test was applied to determine the statistical signifi  cance.     
 
  Figure 6.     ERK phosphorylation, Ca fl  ux, and proximal TCR signaling events are attenuated in BCL11B  F/F  CD4cre DP thymocytes. Immunoblot 
analysis of ERK phosphorylation kinetics in response to stimulation by TCR cross-linking in DP-enriched thymocytes (A) or sorted presignaled CD69   −    DP 
thymocytes (B). In both A and B, ERK phosphorylation was evaluated with anti  –  phospho-p42/p44. The asterisk in A indicates a nonspecifi  c band. (C) Ca 
fl  ux analysis in CD69   −    DP thymocytes. Thymocytes were loaded with Fluo4, surface stained for CD4, CD8, and CD69, and activated as described in the 
Supplemental materials and methods. Fluorescence was recorded for 5 min after stimulation and ionomycin was added to record the maximal calcium 
response. Calcium fl  ux was analyzed in presignaled CD69   −    DP thymocytes using the kinetics platform of the FlowJo and represented as Fluo-4 fl  uorescence 
over time. Notably, when anti-CD4 RM4-5 antibody was used for staining and anti-CD4 GK 1.5 antibody was used for stimulation (see Materials and methods 
and Supplemental materials and methods), the cross-blocking reduced the potency of the anti-CD4 stimulation. (D) Immunoblot analysis of nuclear 
translocation of NFAT4 in response to TCR activation. (E) Immunoblot analysis of ZAP70 and SLP76 phosphorylation. Preparation of enriched DP thymocytes 
and their activation is described in the Supplemental materials and methods. Representative data from multiple experiments are shown. Supplemental 
materials and methods are available at http://www.jem.org/cgi/content/full/jem.20070863/DC1.     3010 BCL11B REGULATES THYMOCYTE SELECTION AND SURVIVAL | Albu et al.
predisposition to cell death. To further support the idea that 
BCL11B promotes survival of T lymphocytes, we used a Jurkat 
cell line model that overexpresses BCL11B, generated through 
retroviral transduction (  22  ). Our results demonstrate that overex-
pression of BCL11B conferred increased protection to apoptosis 
to Jurkat cells (Fig. S4, available at http://www.jem.org/cgi/
content/full/jem.20070863/DC1), suggesting that BCL11B 
supports survival of immature and transformed T cells. 
  We also evaluated the survival of BCL11B-defi  cient 
DP thymocytes in vitro and the results showed that it was 
lower compared with wild-type control (  Fig. 7 B  ), indi-
cating that BCL11B-deficient DP thymocytes are more 
sensitive to spontaneous apoptosis. Similarly, DP thymo-
cytes of BCL11B  F/F    CD4cre/TCR         −    mice also died more 
in vitro (  Fig. 7 C  ), supporting the hypothesis that their en-
hanced apoptosis is the result of death by neglect or an intrinsic 
  Figure 7.     BCL11B  F/F  CD4cre DP thymocytes present enhanced apoptosis independent of TCR signaling, which is only partially rescued by 
transgenic BCL2. (A) Thymic cellularity of BCL11B  F/F CD4cre/TCR     − / −    and  BCL11B F/F /TCR     − / −    mice. Thymic cellularity was calculated as described in 
  Fig. 2 C  . Absolute cell numbers should be multiplied by 10  6 .  Two-tailed  Student ’ s   t   test was applied to determine the statistical signifi  cance. Mice in these 
experiments were between 5 and 8 wk of age. (B) In vitro survival of BCL11B  F/F  CD4cre DP thymocytes. Fresh or cultured thymocytes were stained 
for CD4 and CD8, and with AnnexinV and 7-AAD and analyzed by FACS. Survival of DP thymocytes in vitro was estimated as the frequency of live 
(Annexin V   −  /7-AAD  −   ) cells after 16 h in culture reported to the input population, and represented as the mean   ±   the SD.   n   = 4 pairs of mice. P = 0.034. 
(C) In vitro survival of BCL11B  F/F CD4cre/TCR     − / −    DP thymocytes. Fresh or cultured thymocytes from BCL11B  F/F CD4cre/TCR     − / −    and  BCL11B F/F /TCR     − / −    mice 
were stained, analyzed, and represented as in B.   n   = 4 pairs of mice. P = 0.032. (D) Immunoblot analysis of the indicated proapoptotic and prosur-
vival factors. (E) In vitro survival of BCL11B  F/F  CD4cre/BCL2 DP thymocytes. Fresh or cultured thymocytes from BCL11B  F/F  CD4cre/BCL2 and BCL11B  F/F /BCL2 
mice were stained, analyzed, and represented as in B.   n   = 6 pairs of mice. P = 0.054. (F) Immunoblot analysis showing cleaved caspase 3 in BCL2 
transgenic and nontransgenic BCL11B  F/F  CD4cre and BCL11B  F/F   DP thymocytes. Cleaved caspase 3 levels were quantifi  ed by densitometric analysis and 
normalized to actin. (G) Thymic cellularity of BCL-2/BCL11B  F/F  CD4cre mice. Thymocytes were stained for CD4 and CD8 and analyzed by FACS. Thymic 
cellularity was calculated as described in   Fig. 2 C  . Cell counts should be multiplied by 10  6  . Two-tailed Student  ’  s   t   test was applied to determine the 
statistical signifi  cance.     JEM VOL. 204, November 26, 2007 
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DP thymocytes, i.e., programmed cell death 1 (PD-1), p55 
      adaptor subunit of PI 3-kinase (Pik3r3), and CD5 (  Fig. 8 A  ). 
PD-1, which is a member of B7/CD28 costimulatory recep-
tors, previously demonstrated to alter positive selection when 
transgenically overexpressed in DP thymocytes (  38  ). Interest-
ingly, PD-1 mRNA and protein levels were up-regulated in 
BCL11B-defi  cient DP thymocytes (  Fig. 8, A and B  ), thus 
suggesting that this molecule can be implicated in the mecha-
nisms that alter signaling and positive selection of BCL11B-
defi  cient DP thymocytes. 
  Another candidate gene associated with TCR signaling was 
the       adaptor subunit (Pik3r3), which is an enzyme previously 
shown to be implicated in positive selection downstream of 
TCR engagement and upstream of calcium mobilization (  39  ). 
  In addition, CD5 mRNA levels were reduced in BCL11B-
defi  cient DP thymocytes (  Fig. 8 A  ), and this was not just a 
consequence of the failure to pass positive selection, as the 
surface and intracellular levels of CD5 were also reduced in 
BCL11B-defi  cient presignaled CD69    −    DP thymocytes (  Fig. 8 C   
and not depicted). As expected, CD5 remained reduced in 
postselected CD69  +   DP thymocytes, as well as in CD4 and 
CD8 SP thymocytes (  Fig. 8 C  ). These results collectively 
demonstrate that BCL11B-defi  cient DP thymocytes have 
multiple defects in expression of genes associated with positive 
selection, consistent with the functional defects of BCL11B-
defi  cient DP thymocytes. 
  In regard to survival/apoptosis, mRNA levels of BCLXL 
and BCL2 were modestly down-regulated, suggesting that they 
may be candidate target genes, whereas the mRNA levels for 
the proapoptotic factors deregulated at protein level (  Fig. 7 D  ) 
were found unchanged (not depicted), suggesting that these 
genes are not candidate targets. In addition, the gene encoding 
pleckstrin homology-like domain, family A, member 1 (Phlda1), 
also known as T cell death associated gene 51 (Tdag51), which 
was previously found to induce cell death in diff  erent cell-
ular systems (  40  ), was highly expressed in BCL11B-defi  cient 
thymocytes (  Fig. 8 A  ), suggesting that it may play a role in 
enhanced apoptosis. 
  In addition to genes associated with positive selection and 
survival, two genes encoding membrane-associated proteins, 
CD160 and Ly6c, which are normally not expressed in DP 
thymocytes, were up-regulated BCL11B-defi  cient DP thymo-
cytes (  Fig. 8 A  ). CD160 (BY55) is an Ig-like receptor ex-
pressed in NK, NKT, and cytotoxic T cells, and has broad 
specifi  city binding for classical and nonclassical MHC class I 
molecules (  41  –  43  ). Ly6c is a GPI-anchored cell surface pro-
tein known to mediate inhibitory signals on eff  ector CD4  +   T 
cells (  44  –  46  ). These results suggest that potentially inappro-
priate signals may be initiated in BCL11B-defi  cient DP thymo-
cytes, which may interfere with TCR signaling and the main 
program at this stage of T cell development. 
    DISCUSSION   
  In this study, we investigated how selective removal of BCL11B 
at the DP stage of T cell development impacts positive selection 
and survival of DP thymocytes. Positive selection of both 
  Enhanced apoptosis of BCL11B-defi  cient DP thymocytes 
is mediated through caspase 3, and only partially 
dependent on BCL2 family members 
  To investigate the mechanism by which BCL11B  F/F  CD4cre 
DP thymocytes die, we fi  rst evaluated the levels of cleaved 
caspase 3, which is downstream of both intrinsic and extrinsic 
apoptotic pathways. Cleaved caspase 3 levels were elevated in 
BCL11B-defi  cient DP thymocytes (  Fig. 7 D  ), demonstrating 
the implication of this eff  ector caspase. The reduced survival of 
BCL11B-defi  cient DP thymocytes could be caused by a de-
crease in the levels of BCLXL, which plays a prominent role 
in DP thymocyte survival (  34  ). However, we found only a 
very modest decrease of BCLXL protein levels (  Fig. 7 D  ). As 
survival/apoptosis is determined by the balance between pro-
survival versus proapoptotic factors, we further evaluated the 
protein levels of several proapoptotic factors, and found only 
modest increases in Bim, Puma, Bok, and Bad levels (  Fig. 7 D  ). 
Overall, the balance between proapoptotic/prosurvival factors 
was inclined toward apoptosis. To further clarify whether the 
imbalance in proapoptotic/prosurvival factors is the cause of 
enhanced apoptosis, we provided transgenic BCL2, as BCL2 
and BCLXL were demonstrated to be equally potent in inhib-
iting thymocyte death (  34  –  37  ). In vitro survival of BCL11B-
defi  cient DP thymocytes was improved by provision of BCL2 
transgene (  Fig. 7 E  ), suggesting that BCL2 family proteins play 
a role in survival mediated by BCL11B. The levels of cleaved 
caspase 3 still remained slightly elevated (  Fig. 7 F  ). However, 
the cellularity of the transgenic BCL2/BCL11B-defi  cient 
thymi, including the absolute numbers of DP thymocytes, re-
mained severely reduced (  Fig. 7 G  ), indicating that the survival 
of BCL11B-defi  cient DP thymocytes was not restored in vivo. 
These results suggest that although BCL2 family members play a 
role in the survival defect of BCL11B-defi  cient DP thymocytes, 
other mechanisms are also likely to be involved. Finally, provi-
sion of BCL2 did not restore the CD4 and CD8 SP thymocyte 
numbers or positive selection (  Fig. 7 G   and Fig. S5, available at 
http://www.jem.org/cgi/content/full/jem.20070863/DC1). 
  BCL11B-defi  cient DP thymocytes have altered expression 
of genes involved in TCR signaling, positive selection, 
and survival/apoptosis 
  As BCL11B is a transcription factor, we reasoned that the defects 
of BCL11B-defi  cient DP thymocytes are caused by changes 
in gene expression. We conducted a gene expression profi  ling 
in BCL11B-defi  cient DP thymocytes versus wild-type control 
(unpublished data) and focused our analysis on genes relevant 
for positive selection, signaling, and survival/apoptosis. Expres-
sion of candidate genes was confi  rmed by qRT-PCR (  Fig. 
8 A  ).   To eliminate the possibility that the diff  erences in the 
mRNA levels are a consequence of the absence of postselected 
DP thymocytes in BCL11B  F/F  CD4cre mice, for genes with 
relevance for TCR signaling and positive selection, we also 
tested the mRNA levels in TCR         −  /  −    DP thymocytes, which 
predominantly consist of presignaled DP thymocytes (  Fig. 8 A  ). 
mRNAs for three molecules previously linked to positive se-
lection were found to be deregulated in BCL11B-defi  cient 3012 BCL11B REGULATES THYMOCYTE SELECTION AND SURVIVAL | Albu et al.
were altered in BCL11B-defi  cient DP thymocytes. The re-
duction in the formation and implicit selection of the CD8 
lineage was less severe than that of the CD4 lineage. Interest-
ingly, these results are similar to the phenotypes described 
in mice with defects in genes encoding TCR signaling com-
ponents, such as those of the Ras  –  MEK  –  ERK pathway, in-
cluding MEK1 (  29  ), Ras (  47  ), and ERK1 and ERK2 (  31  ). 
Nevertheless, provision of a transgenic TCR that favors posi-
tive selection of the CD8 lineage did not restore the selection 
and formation of CD8 lineage, strongly suggesting that they 
are altered in the absence of BCL11B. Positive selection and 
formation of the CD4 lineage was severely compromised, and 
provision of a transgenic TCR that favors selection of the 
CD4 lineage did not restore it either. Therefore, these studies 
suggest that the defect in positive selection is not caused by the 
TCR itself, but likely by molecules implicated in TCR signal-
ing and/or a pathway that aff  ects TCR signaling. This idea is 
also supported by previous observations, which demonstrated 
that provision of TCR           in the germline BCL11B-defi  cient 
mice only partially rescued the developmental arrest at the 
     -selection (  48  ), altogether suggesting that BCL11B may di-
rectly or indirectly control signaling components downstream 
of the TCR and/or a pathway that impacts TCR signaling. 
In support of this hypothesis, our results demonstrate that 
signaling through the two major pathways, which are acti-
vated through TCR during positive selection, Ras  –  MEK  –
  ERK pathway, and Ca  2+   fl  ux (  1, 29  –  31, 47, 49  ), is altered in 
BCL11B-defi  cient DP thymocytes. Moreover, phosphory-
lation of ZAP70 and SLP76 was also altered in BCL11B-defi  -
cient DP thymocytes, suggesting a defect in proximal TCR 
signaling and/or in a pathway that proximally impacts TCR 
signaling. There are several transcription factors with roles 
in positive selection known to act distally in TCR signal-
ing, downstream of ERK or calcium signaling activation. 
Such examples include SAP1, which is a direct target of ERK 
phosphorylation (  9  ), its target EGR1 (  10  ), as well as EGR1  ’  s 
target Id3 (  11  ), and NFAT4, which is a target for calcium sig-
naling ( 12  ). Diff  erent from these transcription factors, BCL11B 
seems to have a very unique position, controlling proximal 
events of TCR signaling, and/or a pathway that impacts 
TCR signaling. How does BCL11B specifi  cally direct tran-
scriptional events required for successful positive selection of 
DP-positive thymocytes? We identifi  ed several   “  candidate  ”   
genes previously implicated in positive selection and signaling 
with altered mRNA levels in BCL11B-defi  cient DP thymo-
cytes. One such candidate up-regulated in BCL11B-defi  cient 
DP thymocytes, both at mRNA and protein level, is PD-1, 
which is a member B7/CD28 costimulatory receptors (  50  –  52  ). 
PD-1 was shown to diminish TCR signaling and ERK phos-
phorylation, and to alter positive selection (  38  ) by diminishing 
Zap70 activity by recruitment of the inhibitory SHP-1 and -2 
phosphatases through immunoreceptor-tyrosine inhibi-
tion motif (  38, 53  ). Indeed, not only calcium fl  ux and ERK 
phosphorylation were defective in BCL11B-defi  cient DP 
thymocytes but also phosphorylation of ZAP70, which is 
an indication of its altered function. Thus, the high levels of 
CD4 and CD8 lineages was compromised in BCL11B  F/F  -
CD4cre mice. However, this was not a consequence of a 
failure to rearrange TCR     , as rearrangements proceeded nor-
mally in the absence of BCL11B. The induction of CD69 ex-
pression and up-regulation of CD5 and TCR     , which are 
hall  marks of profi  cient progression through positive selection (  1  ), 
  Figure 8.     Expression of genes implicated in positive selection, TCR 
signaling, and apoptosis is altered in BCL11B-defi  cient DP thymo-
cytes. (A) Ratios of relative mRNA levels of genes involved in positive 
selection and survival/apoptosis in BCL11B-defi  cient DP thymocytes ver-
sus wild type. mRNA levels were quantifi  ed by qRT-PCR, as described in 
the Materials and methods (  22  ), in BCL11B  F/F  CD4cre (KO) and BCL11B  F/F  
(WT), and in BCL11B  F/F CD4cre/TCR     − / −    (KO) and BCL11B  F/F /TCR     − / −    (WT) 
mice. Representative data is presented from multiple experiments. PD-1 
(B) and CD5 (C) surface levels in thymocyte populations. Total thymocytes 
from BCL11B  F/F  CD4cre (KO) and BCL11B  F/F   (WT) mice were stained for CD4, 
CD8, CD69, and PD-1 (B) or CD5 (C) and analyzed by fl  ow cytometry. His-
tograms showing PD-1 (B) and CD5 (C) levels on gated CD69   −    DP,  CD69 +  
DP, CD4, and CD8 SP thymocytes. Data are representative of four inde-
pendent experiments.     JEM VOL. 204, November 26, 2007 
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Except for the modest down-regulation of BCLXL and BCL2, 
we failed to see any diff  erences in the mRNA levels of the 
aforementioned proapoptotic factors, suggesting that these genes 
are not candidate targets. The observation that transgenic BCL2 
failed to rescue cellularity in vivo strongly suggests the impli-
cation of other pathways in the enhanced apoptosis of BCL11B-
defi  cient DP thymocytes. In this regard, the mRNA for Phlda1/
Tdag51 was found to be up-regulated in BCL11B-defi  cient 
DP thymocytes. Interestingly, Phlda1/Tdag51 was found to 
act both on death receptor-dependent and -independent 
pathways (  40, 63  ), raising the possibility that this factor may 
be implicated in the enhanced apoptosis of BCL11B-defi  cient 
DP thymocytes. 
  Overall, the results presented here demonstrate a complex 
and unique role of the BCL11B transcription factor in the con-
trol of both positive selection and survival of DP thymocytes. 
    MATERIALS AND METHODS   
  Mice.     Mice carrying the fl  oxed BCL11B alleles (BCL11B  F/F  ) were gener-
ated in 129S3 background and will be described elsewhere (unpublished data). 
BCL11B  F/F   mice were backcrossed on C57BL/6 background for 5 generations 
using the   “  Speed Congenics  ”   Technology, provided by The Jackson Labo-
ratory, which allowed us to reach a 98% C57BL/6 background. BCL11B  F/F   mice 
were crossed with C57BL/6 CD4Cre transgenic mice (line 4196; Taconic) (  25  ) 
to generate conditional BCL11B  F/F  CD4cre mice. To obtain H-Y TCR/- and 
OT-2 TCR/BCL11B  F/F  CD4cre transgenic mice, were crossed with H-Y 
TCR (  28  ) (Taconic) or OT-2 TCR mice (  27  ) (The Jackson Laboratory). 
To obtain BCL2/BCL11B  F/F  CD4cre transgenic mice, we crossed with BCL2 
transgenic mice (  34  ) (A. Singer, National Cancer Institute, Bethesda, MD). 
TCR         −  /  −    mice were purchased from The Jackson Laboratory. Experiments 
were conducted with 5  –  6 wk old mice, unless specifi  ed. Mice were kept 
under specifi  c pathogen  –  free conditions in the animal care facility of Albany 
Medical College, and all animal procedures were approved by the Institutional 
Animal Care and Use Committee. 
  Cell culture, antibodies, and fl  ow cytometry.     Primary cells were main-
tained in RPMI 1640. DP cells were enriched using anti-CD8 magnetic 
beads (Miltenyi Biotec), resulting in     95% DP thymocytes. The following 
antibodies were used for surface staining: anti-CD4 (clones RMA4-5 and GK1.5), 
-CD8 (clone 53  –  6.7), -TCR      (clone H57-597), -TCR     2 (clone B20.1), 
-HYTCR (clone T3.70), -HSA (clone M1/69), -CD69 (clone H1.2F3), -CD5 
(clone 53  –  7.3), -CD3 (clone 145-2C11), -TCR           (clone GL3), -B220 
(clone RA3-6B2), -F4/80 (clone BM8), -CD11c (clone N418), -CD49b (clone 
DX5), -CD41 (clone MW Reg30; eBioscience), and -TCR     5 antibodies 
(clone MR9-4; BD Biosciences). Intranuclear staining of BCL11B with 
the previously described anti-BCL11B antibodies (  22  ) was conducted after 
staining for surface CD4 and CD8, followed by fi  xation and perme-
abilization with 1% Triton X-100. Determination of apoptosis in fresh 
or 16-h  –  cultured thymocytes was conducted by staining with AnnexinV 
(BD Biosciences) and 7-AAD (eBioscience) after surface staining for CD4 
and CD8. Flow cytometry analysis was conducted on a FACSCanto instru-
ment (BD Biosciences). Sorting of thymocytes was performed on a FACS-
Aria instrument. Flow cytometry data was analyzed using FlowJo software 
(Tree Star, Inc). 
  qRT-PCR.     For evaluation of gene expression, DP thymocytes were either 
sorted or purifi  ed by selection on anti-CD8 magnetic beads. qRT-PCR was 
conducted as previously described (  22  ). The primers for q-PCR were cho-
sen so as to extend products under 200 bp with no formation of primer 
dimers. The relative abundance of each message was normalized to actin and 
calculated as: 2    −  (Ct gene  −  Ct actin)  , where Ct represents the threshold cycle for 
each transcript. Sequence of the primers is available upon request. 
PD-1 in BCL11B-defi  cient DP thymocytes may account for 
altered TCR signaling, and implicitly defective positive selec-
tion. Another candidate gene found to be down-regulated in 
BCL11B-defi  cient DP thymocytes is Pik3r3, which is an un-
derstudied adaptor subunit of PI3-kinase. Previous fi  ndings 
implicated PI3-kinase in positive selection through the cata-
lytic subunit p110      (  39  ). However, it was reported that 
despite a major block in B lymphocyte development, no dis-
ruption of positive selection was observed in the absence of 
the       (Pik3r1) and       (Pik3r2) adaptor subunits (  54, 55  ). Inter-
estingly, in thymocytes of these mice, the expression of the 
third adaptor subunit,       or Pik3r3, was found to be up-regulated. 
Therefore, it is tempting to speculate that the adaptor subunit 
      (Pik3r3), identifi  ed by us as a candidate gene down-regulated 
in BCL11B-defi  cient DP thymocytes, may be the adaptor sub-
unit of PI 3-kinase responsible for positive selection of DP 
thymocytes. Thus, the lower Pik3r3 levels in BCL11B-
defi  cient DP thymocytes may participate in the altered calcium 
fl  ux. In addition to the two molecules implicated in TCR 
signaling, CD5 was found to be reduced both at mRNA and 
protein levels, indicating that positive selection is compro-
mised at multiple levels and in a complex manner. To this end, 
it is also possible that the defect in positive selection in BCL11B-
defi  cient DP thymocytes is not only the result of direct altera-
tions in TCR signaling. Rather, other surface molecules may 
provide signals that perturb TCR signaling, compromising 
positive selection. In this regard, we found increased mRNA 
levels for two membrane-associated proteins, CD160 and Ly6c, 
which are normally not expressed in DP thymocytes, but 
which are able to initiate signaling in NK, CD8  +  , and CD4  +   
T lymphocytes (  41, 45, 46  ). Such signals initiated in DP 
thymocytes may interfere with the normal TCR signaling and 
the program of DP thymocytes. 
  BCL11B-defi  cient DP thymocytes also presented enhanced 
apoptosis. Interestingly, other previously reported defi  ciencies 
in positive selection, associated with defects in CD3      (  56  ), 
Lck (  57, 58, 59  ), MEK1 (  29  ), Ras (  47  ), Raf-1 (  60  ), and ERK1 
and ERK2 (  31  ), were not accompanied by a major impair-
ment in survival, which suggests that the reduced survival of 
BCL11B-defi  cient DP thymocytes may be independent of the 
defect in positive selection. This hypothesis is supported by the 
observation that BCL11B-defi  cient DP thymocytes continued 
to exhibit enhanced death even in the absence of TCR signal-
ing, as demonstrated by the experiments with TCR         −  /  −    mice. 
Interestingly, BCL11B-defi  cient DP thymocytes still survive 
long enough to rearrange TCR     . This phenotype is diff  erent 
from the ROR      defi  ciency, in which altered survival of DP 
thymocytes impairs TCR      rearrangements (  61, 62  ). Of interest, 
BCL11B-defi  cient DN3 thymocytes were also more susceptible 
to apoptosis (  23  ). Thus, it is possible that BCL11B may con-
trol thymocyte survival both at the DP and at earlier stages of 
T cell development. We observed enhanced levels of cleaved 
caspase 3 and an imbalanced proapoptotic/prosurvival factors in 
BCL11B-defi  cient DP thymocytes, and extensively evaluated 
the mRNA levels of multiple proapoptotic and prosurvival 
factors, including BCLXL, BCL2, Bad, Bok, Puma, and Bim. 3014 BCL11B REGULATES THYMOCYTE SELECTION AND SURVIVAL | Albu et al.
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